FDA Inspection 1328430 — Cilag AG
The FDA completed an inspection of Cilag AG on Nov 21, 2025 in Schaffhausen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Schaffhausen (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)